Skip to main content

News

Bioprocess Innovation Center - a test bed for creativity and innovation

Bioprocess Innovation Center - a test bed for creativity and innovation

News   •   Sep 15, 2017 08:40 UTC

Uppsala BIO has asked CEO Lotta Ljungqvist some questions about the Bioprocess Innovation Center that will open its doors at GE’s site in Uppsala in mid-2018.

NLSD 2017: ​Getting the right antibiotics from the start  – New detection method may revolutionise antibiotic treatment

NLSD 2017: ​Getting the right antibiotics from the start – New detection method may revolutionise antibiotic treatment

News   •   Sep 11, 2017 12:20 UTC

Using a new method for rapidly determining whether infection-causing bacteria are resistant or susceptible to antibiotics, Astrego Diagnostics is developing a test, called qUTI, to help patients with symptoms of Urinary Tract Infections (UTIs) receive effective treatment from the first doctor’s appointment. Meet them at NLSDays 2017.

NLSD 2017: ​Administering the correct drug every time  – New technology enables rapid drug control at point-of-care

NLSD 2017: ​Administering the correct drug every time – New technology enables rapid drug control at point-of-care

News   •   Sep 11, 2017 11:03 UTC

DrugLog® is the only device on the market that enables hospital staff to quickly test intravenous drugs at the point-of-care. Developed by Uppsala-based company Pharmacolog, the product has the potential to reduce hospital costs and prevent unnecessary patient suffering by making sure the correct medication is given to the right patient every time. Meet the company at NLSDays 2017.

​NLSD 2017: An opportunity to evaluate and speed-up new projects  – Meet GE Healthcare at the Uppsala BIO booth

​NLSD 2017: An opportunity to evaluate and speed-up new projects – Meet GE Healthcare at the Uppsala BIO booth

News   •   Sep 11, 2017 07:03 UTC

On September 13, between 1 and 2 p.m., Stefan Löfås, Science Director for Strategic Technologies at GE Healthcare, will visit Uppsala BIO’s booth at Nordic Life Science Days. This will be an opportunity for scientists, innovators and smaller companies to receive a commercial appraisal of their innovations and ideas, as well as to get advice on how to speed-up the development of their projects.

​Preventing hernia after abdominal surgery  – New use for the world’s first resorbable synthetic surgical mesh

​Preventing hernia after abdominal surgery – New use for the world’s first resorbable synthetic surgical mesh

News   •   Sep 08, 2017 10:37 UTC

Having invented and developed the world’s first long-term resorbable synthetic surgical mesh, Novus Scientific has already made great contributions to decreasing individual suffering and lowering hospital costs around the world. Now the company is about to put its unique medical device to new use in order to prevent hernia after abdominal surgery. Meet them at NLSDays 2017.

​ArgusEye may help remove industrial bottlenecks: Using biosensor technology to automate production processes

​ArgusEye may help remove industrial bottlenecks: Using biosensor technology to automate production processes

News   •   Sep 07, 2017 08:13 UTC

ArgusEye has developed the world’s first biosensor technology for real-time detection of biomolecular substances in industrial processes. Developed by a team of scientists at Linköping University, the innovation has the potential to greatly improve and speed up the production of everything from food and drinks to pharmaceuticals.

​Hand-held instrument diagnoses nerve damage earlier and more securely

​Hand-held instrument diagnoses nerve damage earlier and more securely

News   •   Jan 30, 2017 12:38 UTC

Lara Diagnostics has developed a portable instrument that makes it easier to discover and follow peripheral nerve damage, something that is particularly common among diabetic patients, even before obvious damage occurs. Lara Diagnostics is one of the companies granted funding in the BIO-X call ‘New diagnostic solutions for disease monitoring’.

​Needle-free probe provides information on how organs and tissues recover after surgery

​Needle-free probe provides information on how organs and tissues recover after surgery

News   •   Jan 30, 2017 12:27 UTC

Senzime has developed an integrated monitoring system that can provide information on the state of a body’s organs. A probe (OnZurf Probe) placed on the tissue surface collects a microdialysis sample that is read by an instrument (CliniSenz Analyzer). Senzime is one of the companies that received funding in the BIO-X call ‘New diagnostic solutions for disease monitoring’.

​Data collection following day surgery promotes health and safety development

​Data collection following day surgery promotes health and safety development

News   •   Jan 30, 2017 12:17 UTC

The IT solution RAPP establishes a direct line between patient and caregiver following day surgery operations. It creates greater security and opportunities for clinical development. RAPP was granted support in the 2016 BIO-X call ‘New diagnostic solutions for disease monitoring’.

Microtechnology enables pain-free glucose monitoring for diabetics

Microtechnology enables pain-free glucose monitoring for diabetics

News   •   Jan 30, 2017 12:08 UTC

Kista-based Ascilion is one of the companies granted funding in the recent BIO-X call ‘New diagnostic solutions for disease monitoring’. It develops an electromechanical sensor that measures the level of glucose in the body without causing discomfort. This makes daily sample taking for people with diabetes a gentler and more pleasant experience.